Article PDF first page preview

First page of Assessment of Quality of Life in Children with Chronic Urticaria using the Children’s Dermatology Life Quality Questionnaire Index (CDLQI): A Retrospective Cohort Study

Background Chronic urticaria (CU) negatively impacts children’s quality of life (QoL), yet data on pediatric CU remain limited. This study assessed CU’s impact on QoL using the Children's Dermatology Life Quality Index (CDLQI). Methods Children (4–16 years) with CU were recruited and completed standardized questionnaires on demographics, CU type, management, and comorbidities. Chart review assessed laboratory data. Patients also completed the Urticaria Control Test (UCT), Urticaria Activity Score over 7 days (UAS7), and CDLQI at study entry. Multivariable logistic regression identified factors associated with clinically poor QoL. Results Seventy-four children (median age =10) were recruited: 39 (52.7%) had chronic spontaneous urticaria (CSU), 21 (27.0%) had chronic inducible urticaria (CIndU), and 14 (16.2%) had both. Most children (n=54; 72.9%) reported a clinically satisfactory (CDLQI ≤ 5), while 20 (27.0%) reported a clinically poor QoL (CDLQI > 5). Factors associated with clinically poor QoL included older age at symptom onset (aOR =1.04; 95% CI=1.01–1.05), elevated C-reactive protein (CRP >5mg/L) (aOR=1.49; 95% CI=1.04–2.13), and history of atopic dermatitis (aOR=1.59; 95% CI=1.18–2.13). In younger children (aged 4 – 10), cold urticaria was associated with clinically poor QoL (aOR=1.44; 95% CI=1.07, 2.00). Conclusion Older age at symptom onset, elevated CRP, atopic dermatitis and cold urticaria are associated with clinically poor QoL in children with CU. These findings highlight the need for targeted interventions, such as psychosocial support and education, to improve patient outcomes

The Author(s). Published by S. Karger AG, Basel
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .
Attribution-NonCommercial